» Articles » PMID: 12759237

Hypoxia-inducible Erythropoietin Signaling in Squamous Dysplasia and Squamous Cell Carcinoma of the Uterine Cervix and Its Potential Role in Cervical Carcinogenesis and Tumor Progression

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 2003 May 22
PMID 12759237
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Tissue hypoxia is a characteristic property of cervical cancers that makes tumors resistant to chemo- and radiation therapy. Erythropoietin (Epo) is a hypoxia-inducible stimulator of erythropoiesis. Acting via its receptor (EpoR), Epo up-regulates bcl-2 and inhibits apoptosis of erythroid cells and rescues neurons from hypoxic damage. In addition to human papillomavirus infection, increased bcl-2 expression and decreased apoptosis are thought to play a role in the progression of cervical neoplasia. Using reverse transcriptase-polymerase chain reaction and Western blotting we showed that HeLa and SiHa cervical carcinoma cells and human cervical carcinomas express EpoR, and that hypoxia enhances EpoR expression. Exogenous Epo stimulated tyrosine phosphorylation and inhibited the cytotoxic effect of cisplatin in HeLa cervical carcinoma cells. Using immunohistochemistry, we examined the expression of Epo, EpoR, p16, hypoxia-inducible factor (HIF)-1alpha, and bcl-2 in benign and dysplastic cervical squamous epithelia and invasive squamous cell carcinomas (ISCCs). EpoR expression in benign epithelia was confined to the basal cell layers, whereas in dysplasias it increasingly appeared in more superficial cell layers and showed a significant correlation with severity of dysplasia. Diffuse EpoR expression was found in all ISCCs. Expression of Epo and HIF-1alpha was increased in dysplasias compared to benign epithelia. Focal Epo and HIF-1alpha expression was seen near necrotic areas in ISCCs, and showed correlation in their spatial distribution. Significant correlation was found between expression of EpoR, and p16 and bcl-2 in benign and dysplastic squamous epithelia. Our results suggest that increased expression of Epo and EpoR may play a significant role in cervical carcinogenesis and tumor progression. Hypoxia-inducible Epo signaling may play a significant role in the aggressive behavior and treatment resistance of hypoxic cervical cancers.

Citing Articles

Characterization of the Genomic Landscape in HPV-positive Cervical and Head and Neck Squamous Cell Carcinomas by Whole Genome Next Generation Sequencing.

Ren J, Ma N, Seckar T, Bassa S, Zetola N, Grover S Cancer Genomics Proteomics. 2025; 22(2):188-207.

PMID: 39993810 PMC: 11880920. DOI: 10.21873/cgp.20496.


Targeting Stress Erythropoiesis Pathways in Cancer.

Vignjevic Petrinovic S, Jaukovic A, Milosevic M, Bugarski D, Budec M Front Physiol. 2022; 13:844042.

PMID: 35694408 PMC: 9174937. DOI: 10.3389/fphys.2022.844042.


Infection by High-Risk Human Papillomaviruses, Epithelial-to-Mesenchymal Transition and Squamous Pre-Malignant or Malignant Lesions of the Uterine Cervix: A Series of Chained Events?.

Barillari G, Bei R, Manzari V, Modesti A Int J Mol Sci. 2021; 22(24).

PMID: 34948338 PMC: 8703928. DOI: 10.3390/ijms222413543.


Role of the erythropoietin receptor in Lung Cancer cells: erythropoietin exhibits angiogenic potential.

Liu X, Tufman A, Behr J, Kiefl R, Goldmann T, Huber R J Cancer. 2020; 11(20):6090-6100.

PMID: 32922549 PMC: 7477424. DOI: 10.7150/jca.36924.


Vasculogenic Mimicry Formation Is Associated with Erythropoietin Expression but Not with Erythropoietin Receptor Expression in Cervical Squamous Cell Carcinoma.

Li Y, Qing X, Tao Q, Xiang L, Gong L, Zhou T Biomed Res Int. 2019; 2019:1934195.

PMID: 30915348 PMC: 6409067. DOI: 10.1155/2019/1934195.


References
1.
Ter Harmsel B, Smedts F, Kuijpers J, Jeunink M, Trimbos B, Ramaekers F . BCL-2 immunoreactivity increases with severity of CIN: a study of normal cervical epithelia, CIN, and cervical carcinoma. J Pathol. 1996; 179(1):26-30. DOI: 10.1002/(SICI)1096-9896(199605)179:1<26::AID-PATH516>3.0.CO;2-E. View

2.
Yamaji R, Okada T, Moriya M, Naito M, Tsuruo T, Miyatake K . Brain capillary endothelial cells express two forms of erythropoietin receptor mRNA. Eur J Biochem. 1996; 239(2):494-500. DOI: 10.1111/j.1432-1033.1996.0494u.x. View

3.
Silva M, Grillot D, Benito A, Richard C, Nunez G, Fernandez-Luna J . Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2. Blood. 1996; 88(5):1576-82. View

4.
Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P . Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 1996; 56(19):4509-15. View

5.
Yasuda Y, Masuda S, Chikuma M, Inoue K, Nagao M, Sasaki R . Estrogen-dependent production of erythropoietin in uterus and its implication in uterine angiogenesis. J Biol Chem. 1998; 273(39):25381-7. DOI: 10.1074/jbc.273.39.25381. View